Clinical administration of new antiepileptic drugs: an overview of safety and efficacy

Epilepsia
D W ChadwickZ A Kadir

Abstract

Gabapentin, lamotrigine, tiagabine, topiramate, vigabatrin, and zonisamide are all administered as add-on therapy for treatment of patients with refractory epilepsy. To date, no comparative randomized trials have been performed that could potentially allow an evidence-based choice to be made between these antiepileptic drugs (AEDs). We report a series of meta-analyses of placebo-controlled, randomized add-on trials in patients with partial epilepsy. Results of these meta-analyses are compared, thus giving broad estimates of the comparative efficacy and tolerability of these AEDs. The efficacy outcome is the odds ratio for the number of patients with a > or = 50% reduction in seizure frequency. Reported side effects are also used as tolerability outcomes, and study withdrawal is used as a global outcome measure. Results are summarized as odds ratios with 95% confidence intervals (CIs). When each outcome is compared among drugs, the 95% CIs overlap. Therefore, no conclusive evidence of a difference in efficacy or tolerability between these AEDs was derived, even though the apparently most effective agent (topiramate) may be twice as effective as the apparently least effective agent (lamotrigine). Comparative randomized studies ar...Continue Reading

References

Sep 1, 1994·Journal of Neurology, Neurosurgery, and Psychiatry·R A GrünewaldJ S Duncan
May 1, 1993·Journal of Neurology, Neurosurgery, and Psychiatry·G J SchapelG Davies
Apr 1, 1996·Current Opinion in Neurology·A G Marson, D Chadwick
Nov 1, 1996·Epilepsy Research·D ChadwickE Garofalo
Jan 1, 1995·Epilepsia·H Meinardi
Jul 12, 2013·BMJ : British Medical Journal·Alan Moses

❮ Previous
Next ❯

Citations

Apr 29, 1998·Molecular Neurobiology·O A Petroff, D L Rothman
May 19, 2001·Neurologic Clinics·J W WhelessC Ghanbari
Aug 16, 2003·Journal of Paediatrics and Child Health·D ReithJ Pelekanos
Dec 12, 2001·Epilepsia·J ArcasV López-Martín
Jun 26, 2003·Epilepsia·Albert P AldenkampRianne Reijs
Nov 1, 1996·British Journal of Clinical Pharmacology·E Perucca
Apr 29, 1998·Current Opinion in Neurology·J W Sander
Jul 21, 1999·Arquivos de neuro-psiquiatria·M M GuerreiroJ Bacaltchuk
Apr 16, 2002·Journal of Child Neurology·Tracy A Glauser, John M Pellock
Apr 1, 1997·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·E Perucca
Jun 17, 2003·Acta Neurologica Scandinavica·K PeetersG Pledger
Apr 19, 2005·Journal of Child Neurology·Tamarah Kagan-KushnirO Carter Snead
Jan 12, 2000·The Annals of Pharmacotherapy·B E GidalJ T Gilman
Mar 19, 2021·Journal of Experimental Pharmacology·Fakher RahimAlireza Malayeri
Sep 25, 1999·Bioorganic & Medicinal Chemistry Letters·P PevarelloM Varasi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.